https://doi.org/10.4081/jbr.2024.12484
Estimation of lipid profile and some inflammatory biomarkers in patients with diabetes mellitus type 2 linked to hypertension
Submitted: March 19, 2024
Accepted: October 22, 2024
Published: December 10, 2024
Accepted: October 22, 2024
Abstract Views: 47
PDF: 14
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Diabetes Mellitus (DM) and hypertension are two common diseases that impact a significant section of the population . Pro-inflammatory mediators such as Interferon Gamma (IFN-γ) and C-Reactive Protein (CRP) levels are proposed to be linked to these diseases. The present study was aimed to explore the link between IFN- γ, CRP and lipid profile levels In type 2 diabetes mellitus (T2DM) connected to hypertension. The current study included 78 patients who had T2DM and 40 samples were collected from healthy people, both aged from 35 to 60 years. The total number of T2DM patients group were divided into two groups: 41 patients with Hypertension (HP) and 37 patients without HP, and according to their Body Mass Index (BMI). In addition, the relationship between gender and these diseases was also investigated. The results showed that the levels of Total Cholesterol (TC), Triglycerides (TG), Low-Density Lipoproteins (LDL), and Very Low-Density Lipoproteins (VLDL) were significantly increased in T2DM patients in both women and men. The results also showed a significant increase in the levels of TC, TG, LDL and VLDL in overweighted T2DM patients with HP. However, the levels of High-Density Lipoprotein (HDL) were significantly decreased in all T2DM patients. Moreover, the levels of CRP were significantly increased in T2DM female and male patients. However, the levels of IFN-γ significantly decreased in T2DM female and male patients. Furthermore, body fat percentage and waist/hip ratio significantly increased and were associated with Fasting Blood Sugar (FBS), TC, and CRP in T2DM patients. The findings confirm that lipid profile and pro-inflammatory parameters, such as CRP and IFN-γ, could have a significant impact on T2DM burden that is connected to the presence of HP. Therefore, regulating of lipid profile and pro-inflammatory parameters (CRP and IFN-γ) could protect against development and progression of T2DM accompanied by HP.
Regufe VMG, Pinto CMCB, Perez PMVHC. Metabolic syndrome in type 2 diabetic patients: a review of current evidence. Porto Biomed J 2020;5;e101.
DOI: https://doi.org/10.1097/j.pbj.0000000000000101
Chen Y, Zhang X-P, Yuan J, et al. Association of body mass index and age with incident diabetes in Chinese adults: a population-based cohort study. BMJ Open 2018;8:e021768.
DOI: https://doi.org/10.1136/bmjopen-2018-021768
Sirait HS, Mohd Said F, Mohamad NA. Successful aspects and impacts of diabetic foot exercise among Indonesian type 2 diabetes mellitus patients: A literature review. Int J Adv Life Sci Res 2024;07:9–16.
DOI: https://doi.org/10.31632/ijalsr.2024.v07i02.002
Brouwer TF, Vehmeijer JT, Kalkman DN, et al. Intensive blood pressure lowering in patients with and patients without type 2 diabetes: A pooled analysis from two randomized trials. Diabetes Care 2018;41:1142–8.
DOI: https://doi.org/10.2337/dc17-1722
Lin B, Liu X, Yao S, Pan Z. Intensive blood pressure control and diabetes mellitus incidence for patients with impaired fasting glucose: a secondary analysis of SPRINT. Int J Hypertens 2023;2023:7533353.
DOI: https://doi.org/10.1155/2023/7533353
Ha M, Choi SY, Kim M, et al.-H. Diabetic nephropathy in type 2 diabetic retinopathy requiring panretinal photocoagulation. Korean J Ophthalmol 2019;33:46.
DOI: https://doi.org/10.3341/kjo.2018.0034
Castelblanco E, Granado-Casa M, Hernandez M, et al. Diabetic retinopathy predicts cardiovascular disease independently of subclinical atherosclerosis in individuals with type 2 diabetes: A prospective cohort study. Front Cardiovasc Med 2022;9:945421.
DOI: https://doi.org/10.3389/fcvm.2022.945421
Ranpise NS, Jamkar P, Langote H. Do fixed dose combinations play an important role in the management of coexistent type two diabetes mellitus and hypertension? Indian J Pharm Educ Res 2015;49:190–9.
DOI: https://doi.org/10.5530/ijper.49.3.4
Hashim N, Madhi R, Ali Z, et al. Study on assessment of reproductive hormones in male patients with type 1 and 2 diabetes mellitus. J Adv Biotechnol Exp Ther 2024;7:328 .
DOI: https://doi.org/10.5455/jabet.2024.d27
Khanna D, Peltzer C, Kahar P, Parmar MS. Body Mass Index (BMI): A screening tool analysis. Cureus 2022;10,7759.
DOI: https://doi.org/10.7759/cureus.22119
Li M, Chi X, Wang Y, et al. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct. Target Ther 2022;7:216.
DOI: https://doi.org/10.1038/s41392-022-01073-0
Hedayatnia M, Asadi Z, Zare-Feyzabadi R, et al. Dyslipidemia and cardiovascular disease risk among the MASHAD study population. Lipids Health Dis 2020;19:42.
DOI: https://doi.org/10.1186/s12944-020-01204-y
Mancusi C, Izzo R, Gioia GD, et al. Insulin resistance the hinge between hypertension and type 2 diabetes. High Blood Press. Cardiovasc Prev 2020;27:515–26.
DOI: https://doi.org/10.1007/s40292-020-00408-8
Linders J, Madhi R, Morgelin M, et al. Complement component 3 is required for tissue damage, neutrophil infiltration, and ensuring NET formation in acute pancreatitis. Eur Surg Res 2020;61:163–76.
DOI: https://doi.org/10.1159/000513845
Liang W, Qi Y, Yi H, et al. The roles of adipose tissue macrophages in human disease. Front Immunol 2022;13:908749.
DOI: https://doi.org/10.3389/fimmu.2022.908749
Cozachenco D, Selles MC, Ribeiro F. C. Interferon-γ as a potential link between diabetes mellitus and dementia. J Neurosci 2019;39:4632–35.
DOI: https://doi.org/10.1523/JNEUROSCI.3046-18.2019
Bai L, Zhou J-B, Zhou T, et al. Incident gout and weight change patterns: a retrospective cohort study of US adults. Arthritis Res Ther 2021;23:69 .
DOI: https://doi.org/10.1186/s13075-021-02461-7
Zhang H, Ni J, Yu C, et al. Sex-based differences in diabetes prevalence and risk factors: A population-based cross-sectional study among low-income adults in China. Front Endocrinol (Lausanne) 2019;10:658.
DOI: https://doi.org/10.3389/fendo.2019.00658
Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and cardiovascular disease: A scientific statement from the American Heart Association. Circulation 2021;143:e984-e1010.
DOI: https://doi.org/10.1161/CIR.0000000000000973
Hussain A, Ali I, Kaleem WA, Yasmeen, F. Correlation between body mass index and lipid profile in patients with type 2 diabetes attending a tertiary care hospital in Peshawar. Pakistan J Med Sci 2019;35:591–57 .
DOI: https://doi.org/10.12669/pjms.35.3.7
Hulkoti V, Acharya S, Shukla S, et al. Visceral adiposity index in type 2 diabetes mellitus (DM) and its correlation with microvascular complications. Cureus 2022;10:7759.
DOI: https://doi.org/10.7759/cureus.31279
Omodanisi EI, Tomose Y, Okeleye BI, et al. Prevalence of dyslipidaemia among type 2 diabetes mellitus patients in the Western Cape, South Africa. Int J Environ Res Public Health 2020;17:8735.
DOI: https://doi.org/10.3390/ijerph17238735
Lara-Castro C, Garvey WT. Intracellular lipid accumulation in liver and muscle and the insulin resistance syndrome. Endocrinol Metab Clin North Am 2008;37:841–56.
DOI: https://doi.org/10.1016/j.ecl.2008.09.002
Ormazabal V, Nair S, Elfeky O, et al. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol 2018;17:122.
DOI: https://doi.org/10.1186/s12933-018-0762-4
Giammanco A, Spina R, Cefalù AB, Averna M. APOC-III: a Gatekeeper in controlling triglyceride metabolism. Curr Atheroscler Rep 2023;2567–76.
DOI: https://doi.org/10.1007/s11883-023-01080-8
Artha I MJ R, Bhargah A, Dharmawan NK, et al. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus. Vasc. Health Risk Manag 2019;15:149–57.
DOI: https://doi.org/10.2147/VHRM.S209830
Wajngarten M, Silva GS. Hypertension and stroke: Update on treatment. Eur Cardiol Rev 2019;14:111–5.
DOI: https://doi.org/10.15420/ecr.2019.11.1
Mill KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol 2020;16:223–37.
DOI: https://doi.org/10.1038/s41581-019-0244-2
Kunz HE, Hart CR, Gries KJ, et al. Adipose tissue macrophage populations and inflammation are associated with systemic inflammation and insulin resistance in obesity. Am J Physiol Metab 2021;321:E105–21.
DOI: https://doi.org/10.1152/ajpendo.00070.2021
Mukherjee N, Lin L, Contreras CJ,Templin AT. β-cell death in diabetes: Past discoveries, present understanding, and potential future advances. Metabolites 2021;11:796.
DOI: https://doi.org/10.3390/metabo11110796
Kartika R, Purnamasari D, Pradipta S, et al. Impact of low interferon-γ and IL-10 levels on TNF-α and IL-6 production by PHA-induced PBMCs in type 2 diabetes mellitus J Inflamm Res 2020;13:187–93.
DOI: https://doi.org/10.2147/JIR.S245064
Kato K, Otsuka T, Saiki Y, et al. Association between elevated C-reactive protein levels and prediabetes in adults, particularly impaired glucose tolerance. Can J Diabetes 2019;43:40-45.e2.
DOI: https://doi.org/10.1016/j.jcjd.2018.03.007
Stanimirovic J, Radovanovic J, Banjac K, et al. Role of C-reactive protein in diabetic inflammation. Mediators Inflamm. 2022;2022:3706508.
DOI: https://doi.org/10.1155/2022/3706508
Kanmani S, Kwon M, Shin M-K, Kim MK. Association of C-reactive protein with risk of developing type 2 diabetes mellitus, and role of obesity and hypertension: A Large Population-Based Korean Cohort Study. Sci Rep 2019;9:4573.
DOI: https://doi.org/10.1038/s41598-019-40987-8
Tian R, Wang L, Qian H, et al. C-reactive protein for predicting cardiovascular and all-cause mortality in type 2 diabetic patients: A meta-analysis. Cytokine 2019;117:59–64.
DOI: https://doi.org/10.1016/j.cyto.2019.02.005
Fukuchi Y, Miura Y, Nabeno Y, et al. Immunohistochemical detection of oxidative stress biomarkers, dityrosine and N&sup.EPSILON.;-(hexanoyl)lysine, and C-reactive protein in rabbit atherosclerotic lesions. J Atheroscler Thromb 2008;15:185–92.
DOI: https://doi.org/10.5551/jat.E543
Venugopal SK, Devaraj S, Yuhanna I, et al. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002;106:1439–41.
DOI: https://doi.org/10.1161/01.CIR.0000033116.22237.F9
Butler AE, Moin ASM, Sathyapalan T, Atkin SL. Components of the complement cascade differ in polycystic ovary syndrome. Int J Mol Sci 2022;23:12232.
DOI: https://doi.org/10.3390/ijms232012232
Li X, Weber NC, Cohn DM, et al. Effects of hyperglycemia and diabetes mellitus on coagulation and hemostasis. J Clin Med 2021;10:2419.
DOI: https://doi.org/10.3390/jcm10112419
How to Cite
Madhi, R., Hashim, N. A., Al-Ali , Z. A., & Tahir, N. T. (2024). Estimation of lipid profile and some inflammatory biomarkers in patients with diabetes mellitus type 2 linked to hypertension. Journal of Biological Research - Bollettino Della Società Italiana Di Biologia Sperimentale. https://doi.org/10.4081/jbr.2024.12484
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.